Virginia Clark

3.4k total citations
57 papers, 1.4k citations indexed

About

Virginia Clark is a scholar working on Hepatology, Epidemiology and Cancer Research. According to data from OpenAlex, Virginia Clark has authored 57 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hepatology, 22 papers in Epidemiology and 11 papers in Cancer Research. Recurrent topics in Virginia Clark's work include Liver Disease Diagnosis and Treatment (16 papers), Hepatitis C virus research (12 papers) and Protease and Inhibitor Mechanisms (9 papers). Virginia Clark is often cited by papers focused on Liver Disease Diagnosis and Treatment (16 papers), Hepatitis C virus research (12 papers) and Protease and Inhibitor Mechanisms (9 papers). Virginia Clark collaborates with scholars based in United States, United Kingdom and Germany. Virginia Clark's co-authors include David R. Nelson, Consuelo Soldevila‐Pico, Roberto J. Firpi, Roniel Cabrera, Kenneth Cusi, Fernando Bril, Cynthia Levy, Giuseppe Morelli, Megan A. Lewis and Joy Peter and has published in prestigious journals such as Gastroenterology, PLoS ONE and Hepatology.

In The Last Decade

Virginia Clark

50 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Virginia Clark United States 20 742 643 349 264 191 57 1.4k
Aliki Taylor United Kingdom 18 219 0.3× 320 0.5× 322 0.9× 613 2.3× 59 0.3× 50 1.7k
Herbert Brill Canada 14 429 0.6× 138 0.2× 506 1.4× 210 0.8× 64 0.3× 39 1.3k
Rena K. Fox United States 15 699 0.9× 697 1.1× 133 0.4× 77 0.3× 53 0.3× 26 1.0k
Mark Levstik Canada 18 1.1k 1.5× 1.1k 1.7× 482 1.4× 54 0.2× 160 0.8× 37 1.6k
Samuel Wagner United States 13 386 0.5× 722 1.1× 175 0.5× 372 1.4× 25 0.1× 25 1.4k
Shibao Feng United States 20 336 0.5× 151 0.2× 192 0.6× 948 3.6× 166 0.9× 52 1.9k
Patricia D. Jones United States 14 400 0.5× 371 0.6× 87 0.2× 210 0.8× 35 0.2× 50 770
Érick Moyneur United States 16 240 0.3× 138 0.2× 78 0.2× 242 0.9× 501 2.6× 43 1.2k
Stephen R. Atkinson United Kingdom 17 727 1.0× 332 0.5× 68 0.2× 80 0.3× 212 1.1× 55 1.1k
Janette K. Merrill United States 14 303 0.4× 110 0.2× 123 0.4× 839 3.2× 47 0.2× 33 1.7k

Countries citing papers authored by Virginia Clark

Since Specialization
Citations

This map shows the geographic impact of Virginia Clark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Virginia Clark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Virginia Clark more than expected).

Fields of papers citing papers by Virginia Clark

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Virginia Clark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Virginia Clark. The network helps show where Virginia Clark may publish in the future.

Co-authorship network of co-authors of Virginia Clark

This figure shows the co-authorship network connecting the top 25 collaborators of Virginia Clark. A scholar is included among the top collaborators of Virginia Clark based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Virginia Clark. Virginia Clark is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Clark, Virginia, et al.. (2025). Diagnosis and Monitoring Pathways Using Non‐Invasive Tests in Patients With Alpha‐1 Antitrypsin Deficiency‐Associated Liver Disease: Results From an Expert Delphi Panel. United European Gastroenterology Journal. 13(8). 1446–1455. 1 indexed citations
3.
Huo, Zhiguang, Virginia Clark, Thiago Beduschi, et al.. (2024). Sirtuin3 promotes the degradation of hepatic Z alpha-1 antitrypsin through lipophagy. Hepatology Communications. 8(2). 2 indexed citations
4.
Clark, Virginia, et al.. (2024). Patients treated with immune checkpoint inhibitors for HCC should be considered for liver transplantation. Clinical Liver Disease. 23(1). e0107–e0107. 1 indexed citations
5.
Gu, Tongjun, Virginia Clark, Jorge Lascano, et al.. (2024). Liver Characterization of a Cohort of Alpha-1 Antitrypsin Deficiency Patients with and without Lung Disease. Journal of Clinical and Translational Hepatology. 0(0). 0–0.
6.
Huo, Zhiguang, Zachary Greenberg, Virginia Clark, et al.. (2024). Plasma Extracellular Vesicle-derived MicroRNA Associated with Human Alpha-1 Antitrypsin Deficiency-mediated Liver Disease. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 1 indexed citations
7.
Huang, Daniel Q., Kai En Chan, Caitlyn Tan, et al.. (2023). Meta‐analysis: Prevalence of significant or advanced fibrosis in adults with alpha‐1‐antitrypsin deficiency. Alimentary Pharmacology & Therapeutics. 58(2). 152–158. 3 indexed citations
8.
King, William, et al.. (2023). Adherence to guideline-directed hepatocellular carcinoma screening: A single-center US experience. World Journal of Hepatology. 15(3). 410–418. 2 indexed citations
9.
Marek, George, Amy Collinsworth, Chen Liu, Mark Brantly, & Virginia Clark. (2021). Quantitative measurement of the histological features of alpha-1 antitrypsin deficiency-associated liver disease in biopsy specimens. PLoS ONE. 16(8). e0256117–e0256117. 4 indexed citations
10.
Bril, Fernando, Michael J. McPhaul, Michael P. Caulfield, et al.. (2019). Performance of Plasma Biomarkers and Diagnostic Panels for Nonalcoholic Steatohepatitis and Advanced Fibrosis in Patients With Type 2 Diabetes. Diabetes Care. 43(2). 290–297. 126 indexed citations
11.
Rahaghi, Franck, Laurel Omert, Virginia Clark, & Robert A. Sandhaus. (2019). Managing the Alpha-1 patient in the ICU: Adapting broad critical care strategies in AATD. Journal of Critical Care. 54. 212–219. 1 indexed citations
12.
Clark, Virginia, George Marek, Chen Liu, et al.. (2018). Clinical and histologic features of adults with alpha-1 antitrypsin deficiency in a non-cirrhotic cohort. Journal of Hepatology. 69(6). 1357–1364. 83 indexed citations
13.
14.
Bril, Fernando, Srilaxmi Kalavalapalli, Virginia Clark, et al.. (2017). Response to Pioglitazone in Patients With Nonalcoholic Steatohepatitis With vs Without Type 2 Diabetes. Clinical Gastroenterology and Hepatology. 16(4). 558–566.e2. 158 indexed citations
15.
Michaels, Anthony, Renumathy Dhanasekaran, David P. Foley, et al.. (2013). Hepatic Preservation Injury: Severity of Hepatitis C Recurrence and Survival After Liver Transplantation. Digestive Diseases and Sciences. 58(5). 1403–1409.
16.
Clark, Virginia, et al.. (2012). Liver Test Results Do Not Identify Liver Disease in Adults With α1-Antitrypsin Deficiency. Clinical Gastroenterology and Hepatology. 10(11). 1278–1283. 40 indexed citations
17.
Clark, Virginia, Renumathy Dhanasekaran, C. Soldevila‐Pico, et al.. (2011). 537 A SUSTAINED VIRAL RESPONSE DRAMATICALLY IMPROVES SURVIVAL IN PATIENTS WITH HEPATITIS C INFECTION AFTER LIVER TRANSPLANT. Journal of Hepatology. 54. S219–S220. 1 indexed citations
18.
Cabrera, Roniel, Davinderbir Pannu, James G. Caridi, et al.. (2011). The combination of sorafenib with transarterial chemoembolisation for hepatocellular carcinoma. Alimentary Pharmacology & Therapeutics. 34(2). 205–213. 80 indexed citations
19.
Firpi, Roberto J., Virginia Clark, Consuelo Soldevila‐Pico, et al.. (2009). The natural history of hepatitis C cirrhosis after liver transplantation. Liver Transplantation. 15(9). 1063–1071. 64 indexed citations
20.
Firpi, Roberto J., Consuelo Soldevila‐Pico, Roniel Cabrera, et al.. (2009). The Use of Cyclosporine for Recurrent Hepatitis C After Liver Transplant: A Randomized Pilot Study. Digestive Diseases and Sciences. 55(1). 196–203. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aliki Taylor Breakdown of academic impact, for papers by Herbert Brill Breakdown of academic impact, for papers by Rena K. Fox Breakdown of academic impact, for papers by Mark Levstik Breakdown of academic impact, for papers by Samuel Wagner Breakdown of academic impact, for papers by Shibao Feng Breakdown of academic impact, for papers by Patricia D. Jones Breakdown of academic impact, for papers by Érick Moyneur Breakdown of academic impact, for papers by Stephen R. Atkinson Breakdown of academic impact, for papers by Janette K. Merrill
Rankless by CCL
2026